Robert C, Grob JJ, Schadendorf D, et al. Outcomes and characteristics of patients (pts) who achieved a complete response (CR) with combination dabrafenib and trametinib (D+T). SMR 2017, abstract 09-3.
Ceritinib versus chemotherapie bij gevorderd ALK-positief NSCLC: ASCEND-4
mrt 2017 | Longoncologie